Certified by Founder Lodge
SolasCure
United Kingdom - Cambridge
START UP
1 Disclosed Funding Rounds $13,422,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SolasCure leverages biomimicry and evidence-based medicine to develop fit for purpose, efficacious wound care products significantly improve the health and wellbeing of patients.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 28 ,2023 | Series B | $13,422,000 |
Wealth Club
Seneca Partners
BRAIN Biotech AG
EVA pharma
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
